Di Nuzzo Private Wealth, Inc. Exelixis, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 51 shares of EXEL stock, worth $2,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 44
15.91%
Holding current value
$2,129
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EXEL
# of Institutions
613Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.2 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$941 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$619 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$492 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...